Elevated Serum CA19-9 Level and Regional Lymphadenopathy in a Young Man with Allergic Bronchopulmonary Aspergillosis

12Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

A 21-year-old man with bronchial asthma who suffered from productive cough; his chest X-rays and computed tomographic (CT) scans revealed central atelectasis and pulmonary infiltrates with paratracheal and hilar lymphadenopathy. The serum CA19-9 level was elevated. He was suspected to have malignant neoplasms on admission, but he was diagnosed with allergic bronchopulmonary aspergillosis (ABPA) by Rosenberg's criteria. After steroid therapy, his symptoms and radiographic findings improved and the serum CA19-9 level decreased. ABPA should be considered in the differential diagnosis of asthmatic patients with or without lymphadenopathy and an elevated serum CA19-9 level.

Cite

CITATION STYLE

APA

Hachiya, T., Koyama, S., Kubo, K., Sekiguchi, M., & Honda, T. (1998). Elevated Serum CA19-9 Level and Regional Lymphadenopathy in a Young Man with Allergic Bronchopulmonary Aspergillosis. Internal Medicine, 37(1), 91–93. https://doi.org/10.2169/internalmedicine.37.91

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free